BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37584500)

  • 1. Limocitrin increases cytotoxicity of KHYG-1 cells against K562 cells by modulating MAPK pathway.
    Hsieh MJ; Lin JT; Chuang YC; Lin CC; Lo YS; Ho HY; Chen MK
    Environ Toxicol; 2023 Dec; 38(12):2939-2951. PubMed ID: 37584500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KHYG-1, a model for the study of enhanced natural killer cell cytotoxicity.
    Suck G; Branch DR; Smyth MJ; Miller RG; Vergidis J; Fahim S; Keating A
    Exp Hematol; 2005 Oct; 33(10):1160-71. PubMed ID: 16219538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shuterin Enhances the Cytotoxicity of the Natural Killer Leukemia Cell Line KHYG-1 by Increasing the Expression Levels of Granzyme B and IFN-γ through the MAPK and Ras/Raf Signaling Pathways.
    Lin JT; Chuang YC; Chen MK; Lo YS; Lin CC; Ho HY; Liu YT; Hsieh MJ
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymethoxylated flavones potentiate the cytolytic activity of NK leukemia cell line KHYG-1 via enhanced expression of granzyme B.
    Saito T; Abe D; Nogata Y
    Biochem Biophys Res Commun; 2015 Jan; 456(3):799-803. PubMed ID: 25511703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dimethyl 2,2-dichlorovinyl phosphate (DDVP) markedly decreases the expression of perforin, granzyme A and granulysin in human NK-92CI cell line.
    Li Q; Nakadai A; Ishizaki M; Morimoto K; Ueda A; Krensky AM; Kawada T
    Toxicology; 2005 Sep; 213(1-2):107-16. PubMed ID: 16002202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetically re-engineered K562 cells significantly expand and functionally activate cord blood natural killer cells: Potential for adoptive cellular immunotherapy.
    Ayello J; Hochberg J; Flower A; Chu Y; Baxi LV; Quish W; van de Ven C; Cairo MS
    Exp Hematol; 2017 Feb; 46():38-47. PubMed ID: 27765614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irradiated KHYG-1 retains cytotoxicity: potential for adoptive immunotherapy with a natural killer cell line.
    Suck G; Branch DR; Keating A
    Int J Radiat Biol; 2006 May; 82(5):355-61. PubMed ID: 16782653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impairment in cytotoxicity and expression of NK cell- activating receptors on human NK cells following exposure to asbestos fibers.
    Nishimura Y; Miura Y; Maeda M; Kumagai N; Murakami S; Hayashi H; Fukuoka K; Nakano T; Otsuki T
    Int J Immunopathol Pharmacol; 2009; 22(3):579-90. PubMed ID: 19822075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation.
    Yagita M; Huang CL; Umehara H; Matsuo Y; Tabata R; Miyake M; Konaka Y; Takatsuki K
    Leukemia; 2000 May; 14(5):922-30. PubMed ID: 10803526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granzyme B and perforin produced by SEC2 mutant-activated human CD4
    Zhang G; Zheng G; Jiang F; Wu T; Wu L
    Int J Biol Macromol; 2021 Nov; 190():284-290. PubMed ID: 34492245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of carbamate pesticides on perforin, granzymes A-B-3/K, and granulysin in human natural killer cells.
    Li Q; Kobayashi M; Kawada T
    Int J Immunopathol Pharmacol; 2015 Sep; 28(3):403-10. PubMed ID: 25921628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of natural killer cell cytotoxicity by interleukin-6: implications for the pathogenesis of macrophage activation syndrome.
    Cifaldi L; Prencipe G; Caiello I; Bracaglia C; Locatelli F; De Benedetti F; Strippoli R
    Arthritis Rheumatol; 2015 Nov; 67(11):3037-46. PubMed ID: 26251193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Live cell evaluation of granzyme delivery and death receptor signaling in tumor cells targeted by human natural killer cells.
    Vrazo AC; Hontz AE; Figueira SK; Butler BL; Ferrell JM; Binkowski BF; Li J; Risma KA
    Blood; 2015 Aug; 126(8):e1-e10. PubMed ID: 26124495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced release and binding of perforin at the immunological synapse underlies the age-related decline in natural killer cell cytotoxicity.
    Hazeldine J; Hampson P; Lord JM
    Aging Cell; 2012 Oct; 11(5):751-9. PubMed ID: 22642232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential markers of NK-92 associated to cytotoxicity against K562 cells.
    Song X; Xu C; Wu X; Zhao X; Fan J; Meng S
    Biologicals; 2020 Nov; 68():46-53. PubMed ID: 32933840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol enhances perforin expression and NK cell cytotoxicity through NKG2D-dependent pathways.
    Lu CC; Chen JK
    J Cell Physiol; 2010 May; 223(2):343-51. PubMed ID: 20082299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transpresentation of interleukin-15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activity.
    Van den Bergh J; Willemen Y; Lion E; Van Acker H; De Reu H; Anguille S; Goossens H; Berneman Z; Van Tendeloo V; Smits E
    Oncotarget; 2015 Dec; 6(42):44123-33. PubMed ID: 26675759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ganoderma lucidum stimulates NK cell cytotoxicity by inducing NKG2D/NCR activation and secretion of perforin and granulysin.
    Chang CJ; Chen YY; Lu CC; Lin CS; Martel J; Tsai SH; Ko YF; Huang TT; Ojcius DM; Young JD; Lai HC
    Innate Immun; 2014 Apr; 20(3):301-11. PubMed ID: 23803412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex vivo detection of primary leukemia cells resistant to granule cytotoxin-induced cell death: a rapid isolation method to study granzyme-B-mediated cell death.
    Grüllich C; Friske V; Finke J
    Ann Hematol; 2008 Sep; 87(9):701-8. PubMed ID: 18437383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phytoncides (wood essential oils) induce human natural killer cell activity.
    Li Q; Nakadai A; Matsushima H; Miyazaki Y; Krensky AM; Kawada T; Morimoto K
    Immunopharmacol Immunotoxicol; 2006; 28(2):319-33. PubMed ID: 16873099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.